4.6 Article

A Comprehensive Model for the Humoral Coagulation Network in Humans

期刊

CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 86, 期 3, 页码 290-298

出版社

WILEY-BLACKWELL
DOI: 10.1038/clpt.2009.87

关键词

-

资金

  1. University of Otago
  2. National Health and Medical Research Council [ID300785]

向作者/读者索取更多资源

Coagulation is an important process in hemostasis and comprises a complicated interaction of multiple enzymes and proteins. We have developed a mechanistic quantitative model of the coagulation network. The model accurately describes the time courses of coagulation factors following in vivo activation as well as in vitro blood coagulation tests of prothrombin time (PT, often reported as international normalized ratio (INR)) and activated partial thromboplastin time (aPTT). The model predicts the concentration-time and time-effect profiles of warfarin, heparins, and vitamin K in humans. The model can be applied to predict the time courses of coagulation kinetics in clinical situations (e. g., hemophilia) and for biomarker identification during drug development. The model developed in this study is the first quantitative description of the comprehensive coagulation network.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Food Science & Technology

The Effect of Australian and Asian Commercial Antivenoms in Reversing the Post-Synaptic Neurotoxicity of O. hannah, N. naja and N. kaouthia Venoms In Vitro

Tam M. Huynh, Wayne C. Hodgson, Geoffrey K. Isbister, Anjana Silva

Summary: The study found that commercial antivenoms can partially reverse post-synaptic neurotoxicity induced by snake venom, with varying degrees and rates. The observations suggest that commercial antivenoms are likely to actively reverse established alpha-neurotoxin-mediated neuromuscular paralysis in snake envenoming and exhibit cross-neutralisation with different antivenoms.

TOXINS (2022)

Article Food Science & Technology

In Vitro Neutralization of the Myotoxicity of Australian Mulga Snake (Pseudechis australis) and Sri Lankan Russell's Viper (Daboia russelii) Venoms by Australian and Indian Polyvalent Antivenoms

Prabhani Thakshila, Wayne C. Hodgson, Geoffrey K. Isbister, Anjana Silva

Summary: This study examined the neutralisation effects of Indian and Australian polyvalent antivenoms on the myotoxicity induced by Sri Lankan Russell's viper and Australian mulga snake venom. The results demonstrated that Indian antivenom prevented the muscle contraction inhibition caused by the viper venom, while Australian antivenom did not. Australian antivenom neutralised the myotoxic effects of mulga snake venom, whereas Indian antivenom did not. The effects of antivenoms on already initiated myotoxicity was similar to physically removing the toxins.

TOXINS (2022)

Article Pharmacology & Pharmacy

Isolation and Characterization of Two Postsynaptic Neurotoxins From Indian Cobra (Naja Naja) Venom

Tam M. Huynh, Anjana Silva, Geoffrey K. Isbister, Wayne C. Hodgson

Summary: This study identified and characterized short-chain and long-chain postsynaptic neurotoxins in the venom of the Indian Cobra. It was observed that antivenom could reverse the neurotoxicity of the long-chain neurotoxin, but not the short-chain neurotoxin.

FRONTIERS IN PHARMACOLOGY (2022)

Article Emergency Medicine

Dedicated nursing care pathway improved management of opioid-poisoned patients in the emergency department: A before-after observational study

Katherine Isoardi, Benjamin Learmont, Benjamin Horan, Geoffrey Isbister

Summary: This study evaluated the effect of a care pathway on the management of opioid-poisoned patients. The results showed that the use of the pathway led to an increase in the proportion of patients receiving naloxone for respiratory depression and an increase in the number of documented observations.

EMERGENCY MEDICINE AUSTRALASIA (2023)

Review Toxicology

A current perspective on snake venom composition and constituent protein families

Theo Tasoulis, Geoffrey K. Isbister

Summary: Snake venoms are complex mixtures of proteins and peptides. Proteomic techniques have advanced our understanding of venom composition. The dominant protein families, including phospholipase A(2), snake venom metalloprotease, three-finger toxins, and snake venom serine protease, play significant roles in envenomation.

ARCHIVES OF TOXICOLOGY (2023)

Article Toxicology

Does snake envenoming cause chronic kidney disease? A cohort study in rural Sri Lanka

Subodha Waiddyanatha, Anjana Silva, Kosala Weerakoon, Sisira Siribaddana, Geoffrey K. Isbister

Summary: There is no significant association between snakebite-associated acute kidney injury (AKI) and chronic kidney disease (CKD) in rural Sri Lankan snakebite patients. However, microalbuminuria is common and it is likely associated with hypertension, diabetes mellitus, and chronic interstitial nephritis in this population.

CLINICAL TOXICOLOGY (2023)

Article Toxicology

Predicting serotonin toxicity in serotonin reuptake inhibitor overdose

Joyce Cooper, Stephen B. Duffull, Geoffrey K. Isbister

Summary: This study aimed to investigate the frequency of serotonin toxicity following overdose of antidepressants that inhibit serotonin reuptake and the factors that influence the probability of serotonin toxicity occurring. The results showed that overdose dose and co-ingestion of certain medications increased the probability of serotonin toxicity, while increasing age and co-ingestion of certain medications decreased the probability.

CLINICAL TOXICOLOGY (2023)

Article Food Science & Technology

In Vitro Efficacy of Antivenom and Varespladib in Neutralising Chinese Russell's Viper (Daboia siamensis) Venom Toxicity

Mimi Lay, Qing Liang, Geoffrey K. Isbister, Wayne C. Hodgson

Summary: In this study, the efficacy of Chinese D. siamensis antivenom alone and in combination with Varespladib was examined for reversing neuromuscular blockade caused by the venom. It was found that the antivenom alone was not able to reverse the neurotoxic and myotoxic effects of the venom at different time points. However, the addition of Varespladib prevented these toxic effects and improved muscle function, indicating its potential as an adjunct treatment. The combination of Varespladib and antivenom did not offer additional benefits compared to Varespladib alone.

TOXINS (2023)

Article Pharmacology & Pharmacy

The influence of flip-flop in population pharmacokinetic analyses

Isabelle H. S. Kuan, Daniel F. B. Wright, Stephen B. Duffull

Summary: Flip-flop is a term used to describe the situation where rate constants in multiexponential models appear to be switched, but it is actually a permutation of parameter values' rank order. This article revisits flip-flop pharmacokinetics and discusses its influence in population pharmacokinetic analyses.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2023)

Article Pharmacology & Pharmacy

Acetaminophen Metabolites on Presentation Following an Acute Acetaminophen Overdose (ATOM-7)

Angela L. L. Chiew, Geoffrey K. K. Isbister, Paul Stathakis, Katherine Z. Z. Isoardi, Colin Page, Kirsty Ress, Betty S. H. Chan, Nicholas A. A. Buckley

Summary: The concentrations of APAP metabolites can predict the onset of hepatotoxicity in patients with acute APAP poisoning. Patients who developed hepatotoxicity had higher concentrations of CYP pathway metabolites and lower concentrations of sulfation metabolites. APAP metabolites may have potential roles in identifying and treating patients with APAP poisoning.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Article Pediatrics

Reality of clonidine poisoning in children and adolescents

Chi Duong, Caitlyn Lovett, MIchael A. Downes, Geoffrey K. Isbister

Summary: The study aimed to describe the severity of clonidine poisonings in a paediatric population referred to a tertiary toxicology service. A retrospective review of clonidine poisoning cases in children or adolescents was conducted, revealing that the poisonings commonly resulted in bradycardia, hypotension, and decreased GCS, but rarely required major interventions.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2023)

Review Pharmacology & Pharmacy

Snakebite-associated thrombotic microangiopathy: a spotlight on pharmaceutical interventions

Tina Noutsos, Geoffrey K. Isbister

Summary: Snakebite is a neglected public health issue in resource poor countries, causing death and disability. Snakebite-associated thrombotic microangiopathy (TMA) leads to acute kidney injury and a risk of chronic kidney disease. The current evidence for therapeutic interventions in snakebite-associated TMA is limited and further research is needed.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2023)

Article Toxicology

Antivenom availability, delays and use in Australia

Geoffrey K. Isbister

Summary: Antivenom is the main treatment for snake envenoming, but availability is a concern in resource poor regions. Early administration and selective use of antivenom are essential for effective treatment. Delays in antivenom administration occur both before and after hospitalization, and improving diagnosis speed and timing of administration are crucial.

TOXICON-X (2023)

Article Toxicology

Lack of cholinergic features in healthcare workers caring for a patient with organophosphate poisoning

Michael A. Downes, Maree Connor, Geoffrey K. Isbister

Summary: This study reports the clinical effects of health care workers caring for an organophosphate poisoned patient and found no evidence of toxicity. The findings support the use of standard personal protective equipment as recommended in guidelines.

CLINICAL TOXICOLOGY (2023)

Article Toxicology

Incidence of serum sickness following Indian polyvalent antivenom therapy in a cohort of snake-envenomed patients in rural Sri Lanka

Subodha Waiddyanatha, Anjana Silva, Supun Wedasingha, Sisira Siribaddana, Geoffrey K. Isbister

Summary: This study aimed to assess the frequency of serum sickness following the administration of Indian polyvalent antivenom in Sri Lanka. The results showed that only a small proportion of patients developed serum sickness, in contrast to other antivenom studies.

CLINICAL TOXICOLOGY (2023)

暂无数据